Douglas Fleming

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

Frederick G. Hayden, Albert D. M. E. Osterhaus, John J. Treanor et al. · New England Journal of Medicine · 1997 · 768 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study

Lone Simonsen, Peter Spreeuwenberg, Roger Lustig et al. · PLoS Medicine · 2013 · 500 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +17

Prevalence of asthma and hay fever in England and Wales.

Douglas Fleming, D. L. Crombie · BMJ · 1987 · 385 citations · Full text

Veterinary Medicine, Public Health Practice, Allergy +4

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

Matthew H. Kulke, Dieter Hörsch, Martyn Caplin et al. · Journal of Clinical Oncology · 2017 · 301 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Human<i>Metapneumovirus</i>as a Cause of Community-Acquired Respiratory Illness1

Joanne Stockton, Iain Stephenson, Douglas Fleming et al. · Emerging infectious diseases · 2002 · 293 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17